Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Preoperative three-dimensional reconstruction
Universal Integrated
Kidney Neoplasms / Surgery
1 trial -
Prepackaged Low-Residue Diet
Universal Integrated
Bowel Preparation Solution
1 trial -
Probiotic
United Therapeutics Europe Ltd
Stress Physiology
1 trial -
Progesterone
Hospital Authority, Hong Kong
Preterm
1 trial -
Progesterone
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Cessation
1 trial -
Progesterone
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Abuse
2 trials -
Progesterone
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use Cessation
1 trial -
Propranolol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Portal Hypertension
1 trial -
Propranolol + Bleomycin
Universal Integrated
Infantile Hemangioma (IH)
1 trial -
Propranolol Hydrochloride
United Therapeutics Europe Ltd
Post-traumatic Stress Disorder
1 trial -
Prostate biopsy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Prostate biopsy guided by PSMA PET/CT
The First People's Hospital of Lianyungang
PSMA PET/CT
1 trial -
Protein intake
Ultragenyx UK Limited
Phenylketonuria
1 trial -
Protein supplementation
Hospital Authority, Hong Kong
Hip Fractures
1 trial -
Prunes
United Therapeutics Europe Ltd
Perimenopausal Bone Loss
1 trial -
Pueraria lobata radix
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Pyridoxal-5'-Phosphate supplement
AVENUE THERAPEUTICS, INC.
Neural Inhibition
1 trial -
QFR
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
QiMeiYan Probiotics
Chongqing Precision Biotech Co., Ltd
IBS - Irritable Bowel Syndrome
1 trial -
Qingre Huashi Granules combined the modified dual therapy
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]
Hospital Authority, Hong Kong
Hemodynamic Instability
1 trial -
RNL-Vascostem®
Cellectar Biosciences
Buerger's Disease
1 trial -
RSV A Memphis 37
United Therapeutics Europe Ltd
Respiratory Syncytial Virus Infections
1 trial -
RT-PCR Test
BRIGHT MINDS BIOSCIENCES INC.
COVID-19
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources